None listed
Conditions
Interventions
Intervention1: Omega 3 fatty acids: Group 1 of perimenopausal women will be prescribed oral supplements of only Omega 3 fatty acids [two 1-g capsules, each capsule containing 180 mg of EPA and 120 mg
Sponsors
Ahalia School of Optometry and Research Center
Eligibility
Inclusion criteria
Inclusion criteria: 1 Perimenopausal and postmenopausal women 2 Women who are willing to participate and comply with the requirements of the study after a detailed explanation of the procedure involved 3 Women with or without previous dry eye disease.
Exclusion criteria
Exclusion criteria: 1 Women following any special diet 2 Women who are under hormonal contraception/hormonal treatments 3 Women who had undergone a hysterectomy due to pathologies. 4 Women with systemic illnesses like Diabetes Mellitus Both type1 and type2 Hypertension Asthma Connective tissue disorders etc 5 Women with ocular diseases affecting the lids conjunctiva cornea anterior uvea and glaucoma 6 Women who are on corticosteroid medications beta-blockers anti-histamines or other drugs that interact with the normal physiology of the tear film
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Type of appropriate oral nutritional supplements in improving ocular health among perimenopausal and postmenopausal women.Timepoint: Baseline, 3 months and 6 months follow up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Influence of oral nutritional supplements in improving the QoL among perimenopausal & postmenopausal women.Timepoint: Baseline, 3 months, 6 months | — |
Countries
India
Contacts
Public ContactVenkataramana Kalikivayi
Ahalia School of Optometry and Research Center
Outcome results
None listed